e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/remodelling in emphysema
L. S. MacKay, L. A. Borthwick, K. Pinnion, C. Ward, J. Lordan, M. Foster, A. J. Fisher, P. A. Corris (Newcastle upon Tyne, Loughborough, United Kingdom)
Source:
Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Session:
Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Session type:
Thematic Poster Session
Number:
721
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. S. MacKay, L. A. Borthwick, K. Pinnion, C. Ward, J. Lordan, M. Foster, A. J. Fisher, P. A. Corris (Newcastle upon Tyne, Loughborough, United Kingdom). Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/remodelling in emphysema. Eur Respir J 2009; 34: Suppl. 53, 721
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Oral presentation: Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/ remodelling in emphysema
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?
Source: Eur Respir J, 56 (4) 2003167; 10.1183/13993003.03167-2020
Year: 2020
IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Arterial remodelling in patients with idiopathic pulmonary fibrosis (IPF) and the possible role of endothelial to mesenchymal transition (EndMT)
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021
The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
Lineage differentiation of pulmonary alveolar fibroblasts
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 39: 133-140
Year: 2012
Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 133-140
Year: 2012
Bronchial epithelial mesenchymal transition (EMT) results is in up-regulation of endothelin-1
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition
Source: Eur Respir J 2015; 45: 1258-1272
Year: 2015
LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Apoptosis of alveolar septal cells contributes to the pathogenesis of emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001
Alveolar epithelial injury and apoptosis
Source: Annual Congress 2007 - Mechanisms in pulmonary fibrosis
Year: 2007
The mechanism of epithelial-mesenchymal transition (EMT) in pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006
PDGFRa and aSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Protective effect of mesenchymal stem cells (MSC) on hypoxia-induced epithelial-mesenchymal transition of alveolar epithelial cells (AEC)
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012
Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling?
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
Impaired tissue repair in emphysema: intrinsic defects in mesenchymal stromal cells or defects in the matrix?
Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept